Schirophrenia, substance misuse, and smoking

Research output: Contribution to journalShort surveypeer-review

5 Scopus citations


The recent literature suggests that enriched genetic loading for substance use disorders, a desire to relieve the subjective distress associated with schizophrenia and its treatment, and 'therapeutic' effects of nicotine may contribute to the high prevalence rates for substance use disorder and smoking among patients with schizophrenia. Substance use disorder is associated with homelessness, aggression, and violence, and increased medical morbidity and mortality in this population. Comprehensive, integrated, outpatient programs that include assertive outreach, case management, and a longitudinal, stepwise, motivational approach to substance use disorder show the most promise. 2000 Lippincott Williams and Wilkins.

Original languageEnglish (US)
Pages (from-to)15-19
Number of pages5
JournalCurrent Opinion in Psychiatry
Issue number1
StatePublished - 2000
Externally publishedYes

ASJC Scopus subject areas

  • Psychiatry and Mental health


Dive into the research topics of 'Schirophrenia, substance misuse, and smoking'. Together they form a unique fingerprint.

Cite this